ATE399002T1 - Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits - Google Patents

Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits

Info

Publication number: ATE399002T1
Authority: AT; Austria
Prior art keywords: skin; mumucoraes; lesions; kits; treatment
Prior art date: 2001-10-03

Application number

AT02775182T

Other languages

English (en)

Inventor

Pinchas Burstein

Original Assignee

Innovative Pharmaceutical Conc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-03

Filing date

2002-10-02

Publication date

2008-07-15

2002-10-02 Application filed by Innovative Pharmaceutical Conc filed Critical Innovative Pharmaceutical Conc

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE399002T1 publication Critical patent/ATE399002T1/de

Links

239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
230000003902 lesion Effects 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract 2
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 abstract 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
238000004132 cross linking Methods 0.000 abstract 1
235000019253 formic acid Nutrition 0.000 abstract 1
210000004400 mucous membrane Anatomy 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT02775182T 2001-10-03 2002-10-02 Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits ATE399002T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/968,771 US7128903B2 (en)	2001-10-03	2001-10-03	Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same

Publications (1)

Publication Number	Publication Date
ATE399002T1 true ATE399002T1 (de)	2008-07-15

Family

ID=25514753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02775182T ATE399002T1 (de)	2001-10-03	2002-10-02	Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits

Country Status (9)

Country	Link
US (3)	US7128903B2 (de)
EP (1)	EP1450771B1 (de)
AT (1)	ATE399002T1 (de)
AU (1)	AU2002341366A1 (de)
DE (1)	DE60227278D1 (de)
DK (1)	DK1450771T3 (de)
ES (1)	ES2309205T3 (de)
IL (1)	IL161177A0 (de)
WO (1)	WO2003028623A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7128903B2 (en) *	2001-10-03	2006-10-31	Innovative Pharmaceutical Concepts (Ipc) Inc.	Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20050020693A1 (en) *	2003-07-24	2005-01-27	Richard Strauss	Pharmaceutical preparations useful as drying agents and for treatment of warts
AU2004200891B2 (en) *	2004-03-01	2010-10-14	Universal Entertainment Corporation	Gaming machine
GB0426308D0 (en) *	2004-12-01	2004-12-29	Byotrol Llc	Preservative and embalming fluids
SE527996C2 (sv) *	2004-12-21	2006-08-01	Tagaway Devices Aps	Anordning för avlägsnande av acrochordons
US8765808B2 (en) *	2005-03-23	2014-07-01	Chs Pharma, Inc.	Treatment or prevention of cancer and precancerous disorders
US8357720B2 (en) *	2005-03-23	2013-01-22	Florida Atlantic University	Treatment or prevention of cancer and precancerous disorders
EP1865972B1 (de) *	2005-03-23	2013-11-06	CHS Pharma, Inc.	Behandlung oder vorbeugung von krebs und präkanzerösen erkrankungen
ITRM20060289A1 (it) *	2006-05-31	2007-12-01	Ranieri Cancedda	Bio membrana ingegnerizzata osteo angiogenica e suoi usi per la rigenerazione di tessuto osseo
CN101138568A (zh) *	2006-09-08	2008-03-12	刘智仁	盐酸在制备治疗糖尿病和前列腺疾病药物中的应用
WO2008052189A2 (en) *	2006-10-26	2008-05-02	Reliant Technologies, Inc.	Micropore delivery of active substances
US20090269390A1 (en) *	2008-04-25	2009-10-29	Medtronic, Inc.	Medical devices, polymers, compositions, and methods for delivering a haloacetate
WO2010033408A1 (en)	2008-09-17	2010-03-25	Mcgrath Patrick D	Antimicrobial sucralfate paste methods and compositions
EP2363136A1 (de) *	2010-03-02	2011-09-07	Fresenius Medical Care Deutschland GmbH	Von Erwachsenenstammzellen abgeleitete Mikrovesikel zur Verwendung bei der therapeutischen Behandlung von Tumorkrankheiten
US20110218552A1 (en) *	2010-03-04	2011-09-08	Hoffman Roger P	System and method of removing skin lesions
RU2482856C2 (ru)	2011-08-05	2013-05-27	Общество С Ограниченной Ответственностью "Оксигон"	Комплексное соединение 2-хлорпропионата цинка и 2-хлорпропионовой кислоты, фармацевтическая композиция для лечения заболеваний кожи, способ ее получения и способ лечения поражений кожи, ногтей и видимых слизистых
RS60435B1 (sr)	2012-09-19	2020-07-31	Innovative Pharmaceutical Concepts (Ipc) Inc	Medicinski aplikator
US9987235B2 (en) *	2013-08-01	2018-06-05	Nicholas L. Abbott	Methods and compositions for modifying mucous membranes
US10588564B2 (en) *	2014-09-30	2020-03-17	Moein Health, LLC	Method and kit for diagnosing and treating neoplastic tissue
NL2014370B1 (nl)	2015-02-27	2017-01-17	Versailles B V	Inrichting en werkwijze voor het aanbrengen van een samenstelling aan de huid of huidlagen.
ES2769673A1 (es) *	2018-12-20	2020-06-26	Philippe Deprez	Composición a base de fenol y sus usos

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4195095A (en) *	1969-04-04	1980-03-25	Sheffner Aaron L	Topical application of thioglycolic acid in the treatment of dermatological conditions
US3924623A (en) *	1974-11-04	1975-12-09	Marion Health And Safety Inc	Tip for applicator swab
CH629100A5 (de)	1979-09-27	1982-04-15	Solco Basel Ag	Hautpraeparat.
DE3035069C1 (de) *	1980-09-17	1982-05-27	Zyma Gmbh	Saures dermatologisches Praeparat
US4588590A (en) *	1981-12-21	1986-05-13	Jaye-Boern Laboratories, Inc.	Method of treating keratosis and compositions useful therefor
US5547988B1 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5385938B1 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Method of using glycolic acid for treating wrinkles
US5166176A (en) *	1986-12-29	1992-11-24	Obagi Zein E	Composition for healing damaged skin
US5276032A (en) *	1989-12-28	1994-01-04	King O Newton	Vision aid and anesthetic composition
US5322856A (en) *	1990-01-22	1994-06-21	Howard Martin	Fortified glutaraldehyde chemical sterilant/disinfectant
TW210287B (de) *	1991-03-01	1993-08-01	Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
EP0627879A1 (de) *	1991-09-20	1994-12-14	CAMIENER, Gerald, W.	Verfahren und zusammensetzungen mit einer aldehydstabilisierenden lösung
MY128187A (en)	1993-06-23	2007-01-31	Icn Switzerland Ag	Preparation for skin and mucous membrane
US5874463A (en) *	1994-10-24	1999-02-23	Ancira; Margaret	Hydroxy-kojic acid skin peel
JP3595012B2 (ja)	1995-02-07	2004-12-02	第一製網株式会社	養殖海苔の赤腐れ病駆除剤
US5700656A (en) *	1995-05-25	1997-12-23	Pig Research Institute, Taiwan	Silver stain for collagen matrix from paraffin embedded tissue
UY24246A1 (es) *	1995-06-06	1996-06-14	Neutrogena Corp	Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
CN1059228C (zh) *	1995-10-11	2000-12-06	范暄民	消毒护肤洗手净
US5791801A (en) *	1996-08-30	1998-08-11	Siebe North, Inc.	Liquid applicator
WO1998017247A1 (en) *	1996-10-23	1998-04-30	The Procter & Gamble Company	Aqueous topical compositions comprising kojic acid, salicylic acid and a water soluble glycol ether
US6235474B1 (en) *	1996-12-30	2001-05-22	The Johns Hopkins University	Methods and kits for diagnosing and determination of the predisposition for diseases
GB9807287D0 (en) *	1998-04-03	1998-06-03	Verdugt Bv	Biocidal compositions
FR2782269B1 (fr) *	1998-08-17	2001-08-31	Oreal	Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
US6573043B1 (en) *	1998-10-07	2003-06-03	Genentech, Inc.	Tissue analysis and kits therefor
SE513436C2 (sv) *	1999-01-21	2000-09-11	Astrid Agholme	Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
FR2792642B1 (fr) *	1999-04-21	2001-06-08	Oreal	Composition cosmetique contenant des particules de resine de melamine-formaldehyde ou d'uree-formaldehyde et ses utilisations
IT1312313B1 (it) *	1999-05-24	2002-04-15	Giorgio Mezzoli	Acido tricloroacetico per la preparazione di soluzioni e/ocomposizioni per il trattamento di lesioni erosive e/o ulcerative.
IT1306171B1 (it) *	1999-07-21	2001-05-30	Wiktor Djaczenko	Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2-
US6391860B1 (en) *	1999-09-09	2002-05-21	Mcgrath Patrick D.	Method for preparation and use of paste formed by controlled reaction of sucralfate with hydrochloric acid
CN1273827A (zh) *	2000-04-24	2000-11-22	潘志荣	一种除癣灭痔杀菌液
US20040198819A1 (en)	2001-06-20	2004-10-07	Young Aiping H.	Biological response modifier composition and uses thereof
US7128903B2 (en) *	2001-10-03	2006-10-31	Innovative Pharmaceutical Concepts (Ipc) Inc.	Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same

2001
- 2001-10-03 US US09/968,771 patent/US7128903B2/en not_active Expired - Lifetime
2002
- 2002-10-02 AU AU2002341366A patent/AU2002341366A1/en not_active Abandoned
- 2002-10-02 DE DE60227278T patent/DE60227278D1/de not_active Expired - Lifetime
- 2002-10-02 AT AT02775182T patent/ATE399002T1/de not_active IP Right Cessation
- 2002-10-02 IL IL16117702A patent/IL161177A0/xx active IP Right Grant
- 2002-10-02 ES ES02775182T patent/ES2309205T3/es not_active Expired - Lifetime
- 2002-10-02 WO PCT/IL2002/000804 patent/WO2003028623A2/en not_active Ceased
- 2002-10-02 US US10/490,213 patent/US20040234625A1/en not_active Abandoned
- 2002-10-02 EP EP02775182A patent/EP1450771B1/de not_active Expired - Lifetime
- 2002-10-02 DK DK02775182T patent/DK1450771T3/da active
2009
- 2009-01-07 US US12/350,039 patent/US8658185B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7128903B2 (en)	2006-10-31
IL161177A0 (en)	2004-08-31
US20030087960A1 (en)	2003-05-08
DE60227278D1 (de)	2008-08-07
US20040234625A1 (en)	2004-11-25
ES2309205T3 (es)	2008-12-16
US20090123568A1 (en)	2009-05-14
EP1450771B1 (de)	2008-06-25
AU2002341366A1 (en)	2003-04-14
EP1450771A4 (de)	2005-04-27
EP1450771A2 (de)	2004-09-01
WO2003028623A2 (en)	2003-04-10
WO2003028623A3 (en)	2004-03-18
DK1450771T3 (da)	2008-10-06
US8658185B2 (en)	2014-02-25

Legal Events

Date	Code	Title	Description
2008-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE399002T1 (de)	2008-07-15	Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits
DE69815122D1 (de)	2003-07-03	Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
ATE314092T1 (de)	2006-01-15	Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
ATE405564T1 (de)	2008-09-15	1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
ATE468137T1 (de)	2010-06-15	Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
HUP0102899A2 (hu)	2002-03-28	Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
BG106825A (en)	2003-02-28	Substituted oxazolidinones and their use in the field of blood coagulation
MXPA05006940A (es)	2006-02-22	Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
SE9704833D0 (sv)	1997-12-22	New formulation
DE69116380D1 (de)	1996-02-22	Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE336997T1 (de)	2006-09-15	Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE60137635D1 (de)	2009-03-26	Verwendung von allopurinol zur behandlung von bluthochdruck
RU2106154C1 (ru)	1998-03-10	Перевязочный материал
RU93032613A (ru)	1996-06-20	Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE59600683D1 (de)	1998-11-19	Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
DK1343472T3 (da)	2006-09-25	Thixotropisk næsespray
JPH0838173A (ja)	1996-02-13	壊死組織を処理するための新規なプロテアーゼ
DE60005952D1 (de)	2003-11-20	Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
NO20020334D0 (no)	2002-01-22	Anvendelse av tosylkloramid(er) for behandling av sykdommer på huden, slimhinner, organer og vev
ATE258229T1 (de)	2004-02-15	Substanz fa-70d, herstellungsverfahren und verwendungen
DE60202446T8 (de)	2006-08-24	Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen
BG105924A (en)	2002-04-30	Composition for the treatment of psoriasis
RU2161503C2 (ru)	2001-01-10	Лечебное средство
BR0014751A (pt)	2002-07-02	Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
ATE203680T1 (de)	2001-08-15	Konjugat zur behandlung von entzündungserkrankungen